CEO, Recce Pharmaceuticals
Stories naming James Graham. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Manufacturing roundup: OncoSil Medical locks in commitments for an $8.7 million raise, Soilco completes its purchase of Martins Fertilizers, Avecho collects an R&D rebate, alongside items on apprenticeships, Myriota, Recce and Swinburne research.
Also thecfigroup.com·divestmergeacquire.com·redchip.com.au·wastemanagementreview.com.au
Profile of Australian biotech Recce Pharmaceuticals, whose synthetic antibiotic candidates target drug-resistant infections, covering its leadership team, FDA designation, clinical trial progress and a government underwriting of its R&D rebate.
Recce Pharmaceuticals secures an $11.2m advance from Endpoints Capital against its research rebate, plus a record $54.9m federal overseas finding, easing pressure on its drug-development spending.
Also Early VC
Radium Capital's explainer on R&D financing describes how ventures including Juice Batteries, Recce Pharmaceuticals, SSW Dairy, Linecrest, NeedleCalm and iCommand used Radium Advances against their R&D tax refunds as non-dilutive debt capital.
Manufacturing roundup: 3D Metalforge raises funds via placement, Recce Pharmaceuticals lands an R&D tax rebate, CoDeAc unveils a nuclear detection solution, A2EP plans a webinar, and Varley Rafael advances local missile production.